Miguel Quijada Álamo, PhD

Post-Doctoral Researcher
University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca
Salamanca, Spain

1. University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain
2. Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.

Presentation(s):

• (1553021) ZMYM3 Mutations Dysregulate Histone Acetylation and Impact the Outcome Of Chronic Lymphocytic Leukemia Patients

  Friday, October 6, 2023
  8:40 AM – 8:50 AM EDT

• (1553652) TRAF3 inactivation in chronic lymphocytic leukemia enhances metabolic cellular plasticity through metabolic reprogramming and associates with adverse prognosis

  Saturday, October 7, 2023
  11:40 AM – 11:50 AM EDT